Recent Posts

Biocon inks deal with Novartis after US nod for biologic drug

Bloomberg Biocon Ltd. said it signed a deal to develop copycat versions of biologic drugs with a unit of Novartis AG, its latest move to become a global player in the next generation of generic medicines after a similar partnership with Mylan NV delivered a recent success. The tie-up with Novartis’s generics unit Sandoz will focus on developing copies, or ...

Read More »

Apple, returning overseas cash, to pay $38bn tax bill

Bloomberg Apple Inc. said it will bring hundreds of billions of overseas dollars back to the US, pay about $38 billion in taxes on the money and spend tens of billions on domestic jobs, manufacturing and data centers in the coming years. The iPhone maker plans capital expenditures of $30 billion in the US over five years and will create ...

Read More »

Brexit EU budget dispute comes down to half

Bloomberg A claim that leaving the European Union would free up an extra 350 million pounds ($485 million) a week for the UK’s state-funded health service was one of the most controversial parts of the 2016 Brexit referendum. It was made by Vote Leave, which emblazoned the figure on the side of its campaign bus, and Foreign Secretary Boris Johnson ...

Read More »
Send this to a friend